Tag: Coumadin

Blood Thinners and the Genetics Behind Drug Response

Editor’s note: Pending an FDA decision, 23andMe no longer offers new customers access to health reports referred to in this post. Customers who purchased prior to November 22, 2013 will still be able to see their health reports, but those who purchased after that time will not. Those customers will have ...

Read more

FDA Updates Label for Commonly Used Blood Thinner to Include Dosing Recommendations Based on Genetics

Warfarin (Coumadin®) is a blood thinner given to people at high risk for the formation of blood clots due to conditions such as deep vein thrombosis, heart valve disease or replacement, and irregular heart beat. The drug is also given to prevent recurrence of pulmonary embolism, heart attack and stroke. If ...

Read more

New Study Shows That Genetic Information Can Improve Administration Of Commonly Used Blood Thinner

Each time a doctor writes a prescription for warfarin (Coumadin®), a blood thinner given to about two million people each year in the United States, it’s a guessing game.  There is no “right” dose of the drug.  Everyone is different and it can take weeks of adjustment to find a patient’s ideal amount of the ...

Read more

Return to top